Abstract
Patent valuation has for a long time been a matter of serious concern within the research-based pharmaceutical industry. However, although specific drug patents have been evaluated technologically, and economists’ general (non-drug-specific) patent valuation models are well developed, direct application to the pharmaceutical industry of existing approaches to valuation is associated with tremendous challenges. This article proposes a systematic framework for analyzing pharmaceutical patent value, which, unlike previous approaches, will integrate technological, commercial, and legal indicators. This work is of great significance to pharmaceutical researchers, managers, and investors in their decision-making in relation to patents and patent value.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
